Clinical trial signals exist, and they deserve context: Sleep Recovery, 2024 documents that in a clinical trial, 7% of patients taking Wegovy reported insomnia as a side effect, a finding that suggests a measurable signal in controlled study conditions, yet does not prove causation for everyone taking the drug
This Business Insider reporting does a nice job exploring why it seems likely that it may be a quiet year for big M&A deals, as many large potential buyers appear set to sit on the sidelines
Navigating the postpartum period presents its own challenges, especially when considering medications like semaglutide for weight management
Users often describe it as heaviness rather than sharp pain
In fact, fatigue is considered a common side effect of the brand-name tirzepatide drug Zepbound
Both trials reported that the higher dose of semaglutide was safe and generally well tolerated